Acrivon Therapeutics, Inc. - Common Stock (NQ:ACRV)
1.380
-0.040
(-2.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 10, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 216,117 |
| Open | 1.390 |
| Bid (Size) | 1.380 (100) |
| Ask (Size) | 1.400 (700) |
| Prev. Close | 1.420 |
| Today's Range | 1.375 - 1.440 |
| 52wk Range | 1.150 - 3.560 |
| Shares Outstanding | 21,925,982 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Registration Momentum Builds Across the Oncology Pipeline
February 17, 2026
Here are the top movers in Thursday's session. ↗
January 08, 2026
These stocks are gapping in today's session ↗
January 08, 2026
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
November 03, 2025
Frequently Asked Questions
Is Acrivon Therapeutics, Inc. - Common Stock publicly traded?
Yes, Acrivon Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Acrivon Therapeutics, Inc. - Common Stock trade on?
Acrivon Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Acrivon Therapeutics, Inc. - Common Stock?
The ticker symbol for Acrivon Therapeutics, Inc. - Common Stock is ACRV on the Nasdaq Stock Market
What is the current price of Acrivon Therapeutics, Inc. - Common Stock?
The current price of Acrivon Therapeutics, Inc. - Common Stock is 1.380
When was Acrivon Therapeutics, Inc. - Common Stock last traded?
The last trade of Acrivon Therapeutics, Inc. - Common Stock was at 06/10/26 04:00 PM ET
What is the market capitalization of Acrivon Therapeutics, Inc. - Common Stock?
The market capitalization of Acrivon Therapeutics, Inc. - Common Stock is 30.26M
How many shares of Acrivon Therapeutics, Inc. - Common Stock are outstanding?
Acrivon Therapeutics, Inc. - Common Stock has 30M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.